Market revenue in 2023 | USD 487.1 million |
Market revenue in 2030 | USD 648.5 million |
Growth rate | 4.2% (CAGR from 2023 to 2030) |
Largest segment | Consulting |
Fastest growing segment | Regulatory Affairs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 56.21% in 2023. Horizon Databook has segmented the Saudi Arabia biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia held a 18.85% share of the MEA market in 2023, which can be attributed to the increasing innovation for new drugs, growing awareness about the benefits of biotechnology & pharmaceutical medications, and rising investments in R&D.
Furthermore, the biotechnology & pharmaceutical outsourcing services help avoid the costs of recruitment, training, and retention of specialized staff for drug innovation in Saudi Arabia.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account